TASLY PHARMACEUTICA GROUP revenue breakdown overview

TASLY PHARMACEUTICA GROUP revenue for the last year amounted to 8.67 B CNY, the most of which — 5.97 B CNY — came from its highest performing source at the moment, Chinese Medicines, the year earlier bringing 5.56 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought TASLY PHARMACEUTICA GROUP 8.64 B CNY, and the year before that — 8.59 B CNY.